Clinical Trial

Investigation of the Effectiveness of Craniosacral Therapy in Patients With Multiple Sclerosis.

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated April 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Although the cause of Multiple Sclerosis (MS), one of the common demyelinating diseases of the central nervous system, has not yet been fully elucidated, autonomic nervous system dysfunction has been suggested in its etiology. Symptoms such as fatigue, problems with bladder, bowel, cardiovascular, sleep, sexual and sweating functions, abnormal sympathetic skin response or decreased heart rate variation support this hypothesis. In the treatment of many neurological diseases such as Multiple Sclerosis, complementary medicine practices and non-traditional therapies have recently been shown to be effective in addition to conventional practices. One of these practices, craniosacral therapy (CST), uses manual palpation and manipulation of the craniosacral system to influence sensory, motor, cognitive and emotional processes in the nervous system. In addition, it is thought that applying external force to certain bone elements can have a positive effect on various symptoms in patients with MS, based on the knowledge that it can be transmitted within the system.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06292312
Lead Sponsor Ankara Yildirim Beyazıt University
Collaborators: Lokman Hekim University
Conditions Multiple Sclerosis
Enrollment 32 participants
Start Date 2024-02-27
Primary Completion 2025-04-15 (estimated)
Study Completion 2025-05-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-30